PRESS RELEASE published on 06/02/2025 at 07:00, 11 months 13 days ago Leadership change at Bellevue Group – ongoing business model adjustments – expected net result for H1 significantly lower vs. prior year Bellevue Group AG announces leadership change with Veit de Maddalena as Executive Chairman, ongoing business model adjustments, and significantly lower expected net result for H1 2025 Net Result Leadership Change Bellevue Group Business Model Adjustments H1 2025
PRESS RELEASE published on 06/02/2025 at 07:00, 11 months 13 days ago Compensation for the Expropriation of SNS REAAL and SNS Bank subordinated Bonds Black Pine Capital offers assistance to holders of expropriated SNS REAAL and SNS Bank subordinated bonds for compensation applications. Deadline already expired Compensation SNS REAAL Black Pine Capital Expropriated Bonds SNS Bank
PRESS RELEASE published on 06/02/2025 at 07:00, 11 months 13 days ago Ipsen S.A. - Lancement du programme de rachat d'actions Ipsen lance un programme de rachat d'actions pour couvrir son programme d'attribution d'actions gratuites. Opération conforme à l'autorisation de l'Assemblée Générale Mixte des actionnaires du 21 mai 2025 Rachat D'actions Actionnaires Salariés Ipsen Programme D'attribution
PRESS RELEASE published on 06/02/2025 at 07:00, 11 months 13 days ago Informations privilégiées / Autres communiqués CARMAT annonce les premières implantations commerciales de son cœur artificiel Aeson en dehors de l'Union européenne, avec deux réalisations en Israël CARMAT Coeur Artificiel Israel Aeson Implantations Commerciales
PRESS RELEASE published on 06/02/2025 at 07:00, 11 months 13 days ago Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
PRESS RELEASE published on 06/02/2025 at 07:00, 11 months 13 days ago Ipsen S.A. - Initiation of the share buy-back program Ipsen appoints investment-services provider for share buy-back program to support employee share-allocation plan. Program approved by Annual General Meeting on 21 May 2025 Share Buy-back Annual General Meeting Ipsen Employee Share-allocation Investment-services Provider
PRESS RELEASE published on 06/02/2025 at 06:55, 11 months 13 days ago Leclanché présentera le Navius MRS-3 au salon Nor-Shipping 2025 Leclanché présentera le Navius MRS-3 au salon Nor-Shipping 2025, un système modulaire innovant pour la décarbonation des flottes maritimes conformément aux réglementations Décarbonation Leclanché Navius MRS-3 Nor-Shipping 2025 Flottes Maritimes
PRESS RELEASE published on 06/02/2025 at 06:55, 11 months 13 days ago Leclanché to Showcase its Navius MRS-3 at Nor-Shipping 2025 Leclanché to showcase Navius MRS-3 at Nor-Shipping 2025 in Oslo. The modular system offers high energy density, aiding vessel decarbonization. Visit booth T01-30 for details Energy Storage Leclanché Navius MRS-3 Maritime Nor-Shipping 2025
PRESS RELEASE published on 06/02/2025 at 06:50, 11 months 13 days ago Daldrup & Söhne AG achieves EBIT margin of 12.7% in 2024 Daldrup & Söhne AG achieves EBIT margin of 12.7% in 2024, with forecast of total operating performance around €52 million in 2025 and EBIT margin between 9% and 12% EBIT Margin Forecast 2024 Daldrup & Söhne AG Total Operating Performance
PRESS RELEASE published on 06/02/2025 at 06:30, 11 months 13 days ago Holcim plans Amrize spin-off for June 23 Holcim Group plans to spin-off its North American business forming Amrize, with trading to begin on June 23, 2025. Amrize rated investment grade, secures $3.4 billion debt financing Holcim Debt Financing Spin-off Investment Grade Amrize
Published on 05/16/2026 at 01:15, 52 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 2 hours 7 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 hours 57 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 3 hours 7 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 5 hours 57 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 7 hours 56 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 8 hours 33 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 10 hours 59 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 11 hours 7 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 15 hours 57 minutes ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 1 day 17 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 8 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES